The renin‐angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis

Authors:
  • AKAna Carla Konno
    Ana Carla Konno
  • SPSandra Regina Perosa
    Sandra Regina Perosa
  • JSJoselita Ferreira Carvalho Santiago
    Joselita Ferreira Carvalho Santiago
  • MBMirian A Boim
    Mirian A Boim
  • DVDaniela Berguio Vidotti
    Daniela Berguio Vidotti
  • PVPedro Paulo Vasconcelos Varella
    Pedro Paulo Vasconcelos Varella
  • LCLuciana Gilbert Costa
    Luciana Gilbert Costa
  • MCMauro Canzian
    Mauro Canzian
  • EYElza Márcia Yacubian
    Elza Márcia Yacubian
  • ASAmérico Ceiki Sakamoto
    Américo Ceiki Sakamoto

Abstract
Summary: Purpose: As reported by several authors, angiotensin II (AngII) is a proinflammatory molecule that stimulates the release of inflammatory cytokines and activates nuclear factor κB (NFκB), being also associated with the increase of cellular oxidative stress. Its production depends on the activity of the angiotensin converting enzyme (ACE) that hydrolyzes the inactive precursor angiotensin I (AngI) into AngII. It has been suggested that AngII underlies the physiopathological mechanisms of several brain disorders such as stroke, bipolar disorder, schizophrenia, and disease. The aim of the present work was to localize and quantify AngII AT1 and AT2 receptors in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis (MTS) submitted to corticoamygdalohippocampectomy for seizure control. Method: Immunohistochemistry, Western blot, and real‐time PCR techniques were employed to analyze the expression of these receptors. Results: The results showed an upregulation of AngII AT1 receptor as well as its messenger ribonucleic acid (mRNA) expression in the cortex and hippocampus of patients with MTS. In addition, an increased immunoexpression of AngII AT2 receptors was found only in the hippocampus of these patients with no changes in its mRNA levels. Discussion: These data show, for the first time, changes in components of renin‐angiotensin system (RAS) that could be implicated in the physiopathology of MTS.

This publication has 31 references indexed in Scilit: